Cell line · CVCL_7225
A2780-DX3
Cancer cell line, Homo sapiens. Ovarian endometrioid adenocarcinoma. 4 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. A2780-DX3. Cell lines, record CVCL_7225. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_7225
On this page
Cell line
As Cellosaurus gives it.
- Name
- A2780-DX3
- Accession
- CVCL_7225
- RRID
- RRID:CVCL_7225
- Synonyms
- A2780/DX3, A2780 DX3, DX3
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Ovarian endometrioid adenocarcinoma (NCIt C7979); Endometrioid carcinoma of ovary (ORDO Orphanet_454723)
- Derived from
- Ovary (in situ)
- Parent
- A2780-DX2 (CVCL_4T96)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers4
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| "Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3). | J Cancer Res Clin Oncol | 1995 | Cellosaurus cites it | PubMed | |
| Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3. | Oncol Res | 1993 | Cellosaurus cites it | PubMed | |
| Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells. | Anticancer Res | 1989 | Cellosaurus cites it | PubMed | |
| Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933. | Cancer Chemother Pharmacol | 1989 | Cellosaurus cites it | PubMed |
Relatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | A2780-DX2 | CVCL_4T96 | Cell lines | |
| Derived from it | A2780-DX4 | CVCL_4T97 | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_7225
GET https://conductscience.org/api/cell-lines/v1/CVCL_7225/problems